Here we report that a new NOD/SCID mouse line harboring a complete null mutation of the common cytokine receptor γ chain (NOD/SCID/IL2rγ null ) efficiently supports development of functional human hemato-lymphopoiesis. Purified human hCD34 + or hCD34 + hCD38cord blood (CB) cells were transplanted into NOD/SCID/IL2rγ null newborns via a facial vein. In all recipients injected with 10 5 hCD34 + or 2x10 4 hCD34 + hCD38 -CB cells, human hematopoietic cells were reconstituted at ~70% of chimerisms. A high percentage of the human hematopoietic cell chimerism persisted for > 24 weeks after transplantation, and hCD34 + bone marrow grafts of primary recipients could reconstitute hematopoiesis in secondary NOD/SCID/IL2rγ null recipients, suggesting that this system can support self-renewal of human hematopoietic stem cells. hCD34 + hCD38 -CB cells differentiated into mature blood cells, including myelomonocytes, dendritic cells, erythrocytes, platelets, and lymphocytes. Differentiation into each lineage occurred via developmental intermediates such as common lymphoid progenitors and common myeloid progenitors, recapitulating the steady-state human hematopoiesis. B cells underwent normal class switching, and produced antigen-specific immunoglobulins. T cells displayed the HLA-dependent cytotoxic function. Furthermore, human IgA-secreting B cells were found in the intestinal mucosa, suggesting reconstitution of human mucosal immunity. Thus, the NOD/SCID/IL2rγ null newborn system might be an important experimental model to study human hemato-lymphoid system.
Introduction
To analyze human immune and hematopoietic development and function in vivo, a number of studies have been tried to reproduce human hematopoiesis in small animal xenotransplantation models 1 human blood mononuclear cells into SCID mice 3 . These initial studies suggested the usefulness of immunodeficient mice for reconstitution of the human lymphoid system from human bone marrow hematopoietic stem cells (HSCs).
After these initial reports, a number of modified SCID models have been proposed to try to reconstitute human immunity 4 . In addition, recombination activating gene (RAG)-deficient strains have been used as recipients in xenotransplantation: T and B cell-deficient Prkdc scid , Rag1 -/-, or Rag2 -/mutant mice [5] [6] [7] were capable of supporting engraftment of human cells. The engraftment levels in these models, however, were still low, presumably due to the remaining innate immunity of host animals 1 .
Non-obese-diabetic/severe combined immunodeficiency (NOD/SCID) mice have been shown to support higher levels of human progenitor cell engraftment than BALB/c/SCID or C.B.17/SCID mice 8 . Levels of human cell engraftment were further improved by treating NOD/SCID mice with anti-asialo GM1 antibodies 9 that can abrogate natural killer (NK) cell activity. Recently, NOD/SCID mice harboring either a null allele at the β 2 -microglobulin gene (NOD/SCID/β2m -/-) 10 or a truncated common cytokine receptor γ chain (γc) mutant lacking its cytoplasmic region (NOD/SCID/γ c -/-) 11, 12 were developed. In these mice, NK as well as T and B cell development and functions are disrupted, because β2m is necessary for MHC class-I mediated innate immunity, and because γc (originally called IL2Rγ chain) is an indispensable component of receptor heterodimers for many lymphoid-related cytokines (i.e., IL-2, IL-7, IL-9, IL-12, IL-15 and IL-21) 13 . Injection of human bone marrow or cord blood (CB) cells into these mice resulted in successful generation of human T and B cells. In our hands, efficiencies of CB cell engraftment
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More recently, transplantation of hCD34 + CB cells into Rag2 -/-γc -/newborns regenerated adaptive immunity mediated by functional T and B cells 14 , suggesting heightened support for xenogeneic transplants especially in the neonatal period. Efficiency of reconstitution of human hematopoiesis may be, however, still suboptimal in these models because chimerisms of human cells are not stable in each experiment 11, 12, 14 . Furthermore, there is little information regarding reconstitution of human myelo-erythroid components in these xenogeneic models.
Two types of mouse lines with truncated or complete null γc mutant [15] [16] [17] have been reported. NOD/SCID/γ c -/and Rag2 -/-γc -/mouse strains harbor a truncated γc mutant lacking the intracellular domain 15 , and therefore, binding of γc-related cytokines to each receptor should normally occur in these models 18 . For example, IL-2R with the null γc mutations would be an αβ heterodimer complex with an affinity ~10 times lower than that of the high affinity αβγ heterotrimer complex in mice with the truncated γc mutant 19 . γc has also been shown to dramatically increase the affinity to its ligands through the receptors for IL-4, IL-7 and IL-15 [20] [21] [22] [23] . Previous studies suggested that γc-related receptors including IL-2Rβ chain and IL-4Rα chain could activate JAKs to some extent in the presence of the extracellular domain of γc, independent of the cytoplasmic domain of γc 24, 25 .
Thus, in order to block the signaling through γc-related cytokine receptors more completely, we made NOD/SCID mice harboring complete null mutation of γc 16 (the NOD/SCID/IL2rγ null strain). By using NOD/SCID/IL2rγ null newborns, we successfully reconstituted myelo-erythroid as well as lymphoid maturation by injecting human CB or highly-enriched CB HSCs at a high efficiency. Reconstitution of human hematopoiesis persisted for a long-term. The developing lymphoid cells were functional for Ig production and HLA-dependent cytotoxic activity. Our data show that the NOD/SCID/IL2rγ null newborn system provides a valuable tool to reproduce human hemato-lymphoid development.
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Materials and Methods

Mice.
NOD.Cg-Prkdc scid IL2rg tmlWjl /Sz (NOD/SCID/IL2rγ null ) and NOD/LtSz-Prkdc scid /B2m null (NOD/SCID/β2m null ) mice were developed at the Jackson Laboratory. The NOD/SCID/IL2rγ null strain was established by backcrossing a complete null mutation at γc locus 16 onto the NOD.Cg-Prkdc scid strain. The establishment of this mouse line has been reported elsewhere 26 . All experiments were performed according to the guideline in the Institutional Animal Committee of Kyushu University.
Cell preparation and transplantation.
CB cells were obtained from Fukuoka Red Cross Blood Center. CB cells were harvested after written informed consent. Mononuclear cells were depleted of Lin + cells using mouse anti-hCD3, hCD4, hCD8, hCD11b, hCD19, hCD20, hCD56, and human glycophorin A (hGPA) monoclonal antibodies (BD Immunocytometry, San Jose, CA).
Samples were enriched for hCD34 + cells by using anti-hCD34 microbeads (Miltenyi Biotec, Auburn, CA). These cells were further stained with anti-hCD34 and hCD38 antibodies (BD immunocytometry), and were purified for Lin -CD34 + CD38 -HSCs by a FACSVantage (Becton Dickinson, San Jose, CA). 10 5 Lin -hCD34 + cells or 2x10 4 Lin -hCD34 + hCD38cells were transplanted into irradiated (100 cGy) NOD/SCID/IL2rγ null or NOD/SCID/β2m null newborns via a facial vein 27 within 48hrs of birth. 
Examination of hematopoietic chimerism.
Methylcellulose culture assay
Bone marrow cells of recipient mice were stained with anti-hCD34, hCD38, hCD45RO, hCD123, and lineage antibodies. Human HSCs, CMPs, GMPs, and MEPs were purified according to the phenotypic definition 28,29 by using a FACSVantage (Beckton Dickinson).
One hundred cells of each population were cultured in methylcellulose media (Stem Cell Technologies, Vancouver, Canada) supplemented with 10% BSA, 20 g/ml steel factor, 20 ng/ml IL-3, 20ng/ml IL-11, 20ng/ml Flt3 ligand, 50ng/ml GM-CSF, 4 U/ml Epo, and 50ng/ml Tpo. Colony numbers were enumerated on day 14 of culture.
Histological analysis.
Tissue samples were fixed with 4% paraformaldehyde and dehydrated with graded alcohol.
After treatment with heated citrate buffer for antigen retrieval, paraformaldehyde-fixed paraffin-embedded sections were immunostained with mouse anti-hCD19, human IgA, hCD3, hCD4, hCD8, and hCD11c antibodies (Dako Cytomation, Carpinteria, CA). Stained specimens were observed by a confocal microscopy (Carl Zeiss, Germany).
Enzyme-linked immunosorbent assay (ELISA).
Human Ig concentration in recipient sera was measured by using a human immunoglobulin assay kit (Bethyl, Montgomery, IL). For detection of ovalbumin (OVA)-specific human IgM and IgG antibodies, 5 recipient mice were immunized twice every two weeks with 100 µg of OVA (Sigma, St. Louis, MI) that were emulsified in aluminum hydroxide (Sigma).
Sera from OVA-treated mice were harvested 2 weeks after the second immunization.
OVA was plated at s concentration of 20 µg/ml on 96 microtiter wells at 4 o C overnight.
After washing and blocking with bovine serum albumin, serum samples were incubated in
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Cytotoxicity of alloantigen-specific human CD4 + and CD8 + T-cell lines.
Alloantigen-specific human CD4 + and CD8 + T-cell lines were established according to the method as reported 31 
Results
Reconstitution of human hematopoiesis is achieved in NOD/SCID/IL2rγ null mice
NOD/SCID/IL2rγ null mice lacked mature murine T or B cells evaluated by FACS, and displayed extremely low levels of NK cell activity 31 . This mouse line can survive more than 15 months 31 since it does not develop thymic lymphoma, usually a fatal disease in the immune-compromised mice with NOD background 32 .
Lin -hCD34 + CB cells contain HSCs, and myeloid and lymphoid progenitors 28, 29 .
We and others have reported that engraftment of human CB cells, which contain hematopoietic stem and progenitor cells, was efficient in NOD/SCID/β2m -/and RAG2 -/-/γ c -/mice especially when cells were transplanted at the neonatal period 14, 33 . We therefore transplanted purified Lin -hCD34 + CB cells into sublethally-irradiated NOD/SCID/IL2rγ null newborns via a facial vein 27 .
We first transplanted 10 5 Lin -hCD34 + CB cells from 3 independent donors into 5 NOD/SCID/IL2rγ null newborns, and found that the NOD/SCID/IL2rγ null newborn system is very efficient for supporting engraftment of human hematopoietic progenitor cells. Table   1 shows percentages of hCD45 + cells in these mice 3 months after transplantation.
Strikingly, the average engraftment levels were ~70% in both the bone marrow and the peripheral blood. As compared to 4 control NOD/SCID/β2m -/recipient mice transplanted from the same donors, engraftment levels of hCD45 + cells in NOD/SCID/IL2rγ null mice were significantly higher (Table 1) . Table 2 shows the analysis of human hematopoietic cell progeny in mice transplanted with human Lin -hCD34 + CB cells. In the peripheral blood, hCD45 + cells included hCD33 + myeloid, hCD19 + B and hCD3 + T cells in all mice analyzed ( Figure 1A and Table 2 ). We then analyzed the reconstitution of erythropoiesis and thrombopoiesis in these mice. Anti-human glycophorin A (hGPA) antibodies recognized human erythrocytes, while mTer119 antibodies 34 recognized GPA-associated protein on murine erythrocytes, respectively ( Figure 1B ). Human and murine platelets could also be stained with anti-human and murine CD41a, respectively ( Figure 1B ). Circulating hGPA + erythrocytes and hCD41a + platelets were detected in all 3 mice analyzed ( Figure 1B , right panels).
hGPA + erythroblasts and hCD41a + megakaryocytes were detected as 9.5 + 6.2% (n=5) and In all engrafted mice, the bone marrow and the spleen contained significant numbers of hCD11c + dendritic cells as well as hCD33 + myeloid cells, hCD19 + B cells, and hCD3 + T cells ( Table 2 and Figure 1C ). hCD11c + dendritic cells coexpressed HLA-DR that is essential for antigen presentation to T cells ( Figure 1D ). In contrast, in the thymus, the majority of cells were composed of hCD3 + T cells and rare hCD19 + B cells ( Table 2 ). Figure 2A shows the change in the percentage of circulating hCD45 + cells in another set of NOD/SCID/IL2rγ null newborns injected with 2x10 4 Lin -hCD34 + CB cells.
Surprisingly, the level of hCD45 + cells in the blood was unchanged, and was maintained at a high level even 24 weeks after transplantation. Mice did not develop lymphoid malignancies or other complications. Furthermore, we tested the re-transplantability of human HSCs in primary recipients. We sacrificed mice at 24 weeks after the primary transplant of hCD34 + cells, purified 1-5x10 4 hCD34 + cells from primary recipient bone marrow cells, and re-transplanted them into NOD/SCID/IL2rγ null newborns. In all 3 experiments, secondary recipients successfully reconstituted human hematopoiesis at least until 12 weeks post-transplant, when we sacrificed mice for the bone marrow analysis ( Figure 2B ). Thus, the NOD/SCID/IL2rγ null newborn system can support human hematopoiesis for a long-term.
Human cord blood hematopoietic stem cells produced myeloid and lymphoid cells via developmental intermediates in the NOD/SCID/IL2rγ null bone marrow
The Lin -hCD34 + CB fraction contains early myeloid and lymphoid progenitors as well as HSCs 28 . To verify differentiation into all hematopoietic cells can be initiated from human HSCs in the NOD/SCID/IL2rγ null newborn system, we transplanted Lin -hCD34 + hCD38 -CB cells that contain the counterpart population of murine long-term HSCs 35 , and are highly enriched for human HSCs 36, 37 . 15-20% of hCD34 + CB cells were hCD38 -(data not shown). Mice transplanted with 2x10 4 Lin -hCD34 + hCD38cells displayed successful For personal use only. on November 16, 2017. by guest www.bloodjournal.org From reconstitution of similar proportion of human cells as compared to mice reconstituted with 1x10 5 Lin -hCD34 + cells at 12 weeks post-transplant (Table 2) . In another experiment, mice injected with 2x10 4 Lin -hCD34 + hCD38cells exhibited the high chimerism (>50%) of circulating human blood cells even 24 weeks after transplantation (not shown), suggesting the long-term engraftment of self-renewing human HSCs.
In all mice injected with Lin -hCD34 + hCD38cells, hGPA + erythroid cells and hCD41a + megakaryocytes were present (not shown). We then tested whether differentiation of Lin -hCD34 + hCD38 -HSCs in the NOD/SCID/IL2rγ null mouse microenvironment can recapitulate normal developmental processes in the human bone marrow. We and others have reported that phenotypically-separable myeloid and lymphoid progenitors are present in the steady-state normal bone marrow in both mice 38, 39 and humans 28, 29 . Figure 2C shows the representative FACS analysis data of recipient's bone marrow cells.
In all 3 mice tested, the bone marrow contained the hCD34 + hCD38 -HSC 36, 37 and the hCD34 + hCD38 + progenitor fractions 28 . The 
Development of human systemic and mucosal immune systems in NOD/SCID/IL2rγ null mice
We further evaluated development of the human immune system in NOD/SCID/IL2rγ null recipients. In the thymus, thymocytes were mostly consisted of hCD3 + T cells with scattered hCD19 + B cells ( Figures 3A and 3B ). This is reasonable since the normal murine thymus contain a small number of B cells in addition to T cells 40 In the spleen, lymphoid follicle-like structures were seen ( Figures 3D and 3E) ,
where predominant hCD19 + B cells were associated with surrounding scattered hCD3 + T cells ( Figure 3F ). Development of mesenteric lymph nodes was also observed, where the similar follicle-like structures consisted of human B and T cells were present (not shown).
In the bone marrow and the spleen, nucleated cells in each organ contained hCD34 + hCD19 + proB, hCD10 + hCD19 + immature B, and hCD19 + hCD20 + mature B cells ( Figure 4B ). Supplementary Table) . These data collectively suggest that class-switching can effectively occur in NOD/SCID/IL2rγ null mice.
The intestinal tract is one of the major sites for supporting host defense against exogenous antigens. Since bone marrow and spleen hCD19 + B cells contained a
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Thus, human CB cells could reconstitute cells responsible for both systemic and mucosal immunity in the NOD/SCID/IL2rγ null newborn system.
Function of adaptive human immunity in engrafted NOD/SCID/IL2rγ null mice
Five NOD/SCID/IL2rγ null mice reconstituted with 3 independent human CB samples were immunized twice with ovalbumin (OVA) at 3 months post-transplantation.
Two weeks after immunization, sera were collected from these immunized mice, and were subjected to ELISA to quantify OVA-specific human IgG and IgM. As shown in Figure   5A , significant levels of OVA-specific human IgM and IgG were detected in all serum samples from immunized mice, but not in samples from non-immunized engrafted mice.
Thus, the adaptive human immune system properly functioned in the NOD/SCID/IL2rγ null strain to produce antigen-specific human IgM and IgG antibodies.
We next tested the alloantigen-specific cytotoxic function of human T cells developed in NOD/SCID/IL2rγ null recipients. hCD3 + T cells isolated from the spleen of NOD/SCID/IL2rγ null recipients were cultured with allogeneic B-LCL (TAK-LCL). We established 8 hCD4 + and 10 hCD8 + T-cell clones responding LCL-specific allogeneic antigens. We then estimated cytotoxic activity of these T cell clones in the presence or absence of anti-HLA-DR and anti-HLA class I antibodies. We randomly chose 3 each of CD4 and CD8 clones for further analysis ( Figure 5B) . A 51 Cr release assay revealed that both hCD4 + and hCD8 + T cell clones exhibited cytotoxic activity against allogeneic TAK-LCL, whereas they showed no cytotoxicity against KIN-LCL, a cell line not sharing HLA class I or II with TAK-LCL. Cytotoxic activity of hCD4 + and hCD8 + T cell clones was significantly inhibited by the addition of anti-HLA-DR and anti-HLA class I antibodies, respectively. These data clearly demonstrate that human CB-derived T cells can exhibit cytotoxic activity in an HLA-restricted manner.
Discussion
Xenogeneic transplantation models have been extensively used to study human hematopoiesis in vivo 1, 41, 42 . In the present study, we describe a new xenogeneic transplantation system that effectively supports human hemato-lymphoid development of all lineages for a long-term. NOD/SCID/IL2rγ null newborns exhibited very efficient reconstitution of human hematopoietic and immune systems after intravenous injection of a relatively small number of CB cells. In our hands, NOD/SCID/IL2rγ null newborns displayed a significantly higher chimerism of human blood cells as compared to NOD/SCID/β2m -/newborns under an identical transplantation setting (Table 1 ). This result directly shows that the IL2rγ null mutation has a merit on human cell engraftment over the β2m -/mutation.
One of the critical problems in the NOD/SCID strain for the use of recipients is that this mouse line possesses a predisposition to thymic lymphoma due to an endogenous ectropic provirus (Emv-30) 32 . Because of this, NOD/SCID and NOD/SCID/β2m -/mice have the short mean life span of 8.5 and 6 months, respectively, while NOD/SCID/IL2rγ null mice did not develop thymic lymphoma surviving >15 months 31 , which allows a long-term experimentation.
In our study, NOD/SCID/IL2rγ null newborns injected with 1x10 5 hCD34 + CB cells via a facial vein consistently displayed high levels of chimerism of human hematopoiesis (50-80%) ( Table 1 ). This model is comparable to, or may be more efficient than the Rag2 -/-γc -/newborn model where intrahepatic injection of 0.4-1.2 x 10 5 hCD34 + CB cells generated variable levels of chimerism of human cells (5-65%) 14 . This slight difference of engraftment efficiency, however, could reflect the homing efficiency of HSCs by each injection route. The NOD/SCID/IL2rγ null newborn model might be more efficient than the NOD/SCID/γ c -/adult model in which the majority of recipients showed ~30% chimerism of human cells after transplantation of 5 x 10 4 hCD34 + CB cells 11 . Although we did not test NOD/SCID/γ c -/newborns side by side in this study, we have found that the engraftment level of hCD34 + cells of human acute myelogenous leukemia is ~3-fold higher in newborns than adults in the NOD/SCID/IL2rγ null strain (Ishikawa et. al., manuscript in preparation). Therefore, it remains unclear whether the IL2rγ null mutation has a significant ) , further confirming the advantage of the NOD/SCID/IL2rγ null model. We also showed that, consistent with a previous report using the Rag2 -/-γc -/model 14 Our data directly show that the most primitive hCD34 + hCD38 -CB cells are capable of generating the human myelo-erythroid system in addition to the immune system in the NOD/SCID/IL2rγ null recipients. The emergence of circulating hCD33 + myelomonocytic cells after transplantation of human CB cells has been reported in the NOD/SCID/β2m -/newborn 33 and the NOD/SCID/γ c -/adult 11 systems. Development of human erythropoiesis, however, has not been obtained in previous models, although it has been reported that NOD/SCID mice can support terminal maturation of hCD71 + erythroblasts that were induced ex vivo from human HSCs by culturing with human cytokines 43 . We showed for the first time that human erythropoiesis and thrombopoiesis can develop in mice from primitive hCD34 + hCD38cells, as evidenced by the presence of erythroblasts and megakaryocytes in the bone marrow and of circulating erythrocytes and platelets in NOD/SCID/IL2rγ null recipients. It is important to note that the hCD34 + hCD38 -CB HSC population generated myeloid-and lymphoid-restricted progenitor populations such as CMPs, GMPs, MEPs and CLPs in the bone marrow (Figures 2E and 2F) . Thus, the NOD/SCID/IL2rγ null microenvironment might be able to support physiological developmental steps of myelopoiesis and lymphopoiesis initiating from the primitive HSC stage.
In summary, we show that the NOD/SCID/IL2rγ For personal use only. on November 16, 2017. by guest www.bloodjournal.org From Table 1 For personal use only. on November 16, 2017. by guest www.bloodjournal.org From Table 2 For personal use only. on November 16, 2017. by guest www.bloodjournal.org 
